Literature DB >> 11711635

Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo.

G A Prince1, M G Ottolini, A Moscona.   

Abstract

The envelope of human parainfluenza virus type 3 (HPF3) contains two viral glycoproteins, the hemagglutinin-neuraminidase (HN) protein and the fusion (F) protein. In a previous study, highly fusogenic variant HPF3 viruses were isolated, including two, C-0 and C-22, that exhibit increased avidity for sialic acid receptors due to single amino acid changes in the HN protein and one, C-28, that has decreased neuraminidase activity relative to that of the wild type (wt) and is delayed in the release of virus particles into the supernatant fluid. These variants form very large plaques and destroy a cell monolayer more rapidly than does wt HPF3 in cell culture. These variant viruses allowed us to formulate hypotheses about the roles of HN in pathogenesis. We investigated the behavior of wt HPF3 and the three variant viruses in the cotton rat model. In the cotton rat, there was no delayed clearance of any of the variant viruses compared to that of the wt. The variant plaque morphology was preserved in vivo, and there was no reversion to the wt phenotype in the infected animals. In spite of a slight advantage of wt virus in viral titer, there were no differences in the severities of peribronchiolitis between wt viruses and the variants. However, there were marked differences in severities in alveolitis and interstitial pneumonitis when each of the three variants was compared to the wt, with the variants causing enhanced disease. Thus, despite similar or lower viral titers and similar clearance rates, the variants caused more extensive disease in the lung. The results show that mutations in HN conferring altered fusion properties in cell culture also confer striking differences in the ability of HPF3 to cause extensive disease in the cotton rat lung and that this effect is dissociated from any effect on viral replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711635      PMCID: PMC116141          DOI: 10.1128/JVI.75.24.12446-12451.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.

Authors:  S Crennell; T Takimoto; A Portner; G Taylor
Journal:  Nat Struct Biol       Date:  2000-11

Review 2.  Structure and diversity of influenza virus neuraminidase.

Authors:  P M Colman; C W Ward
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

3.  A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.

Authors:  M T Murrell; M Porotto; O Greengard; N Poltoratskaia; A Moscona
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus).

Authors:  G A Prince; J P Prieels; M Slaoui; D D Porter
Journal:  Lab Invest       Date:  1999-11       Impact factor: 5.662

5.  Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.

Authors:  M Porotto; O Greengard; N Poltoratskaia; M A Horga; A Moscona
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Analysis of human parainfluenza virus 3 receptor binding variants: evidence for the use of a specific sialic acid-containing receptor.

Authors:  A Moscona; R W Peluso
Journal:  Microb Pathog       Date:  1996-03       Impact factor: 3.738

7.  Biological consequences of neuraminidase deficiency in Newcastle disease virus.

Authors:  G W Smith; L E Hightower
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

8.  Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease.

Authors:  G A Prince; F Denamur; M Deschamps; N Garçon; J P Prieels; M Slaoui; C Thiriart; D D Porter
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

9.  The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.

Authors:  O Greengard; N Poltoratskaia; E Leikina; J Zimmerberg; A Moscona
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

Authors:  G A Prince; V G Hemming; R L Horswood; R M Chanock
Journal:  Virus Res       Date:  1985-10       Impact factor: 3.303

View more
  9 in total

1.  A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo.

Authors:  Anne Moscona; Matteo Porotto; Samantha Palmer; Caroline Tai; Lori Aschenbrenner; Gallen Triana-Baltzer; Qi-Xiang Li; David Wurtman; Stefan Niewiesk; Fang Fang
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Characterization of human metapneumovirus infection of myeloid dendritic cells.

Authors:  Maria C Tan; Lorenzo Battini; Ana C Tuyama; Salvador Macip; Guillermina A Melendi; Maria-Arantxa Horga; G Luca Gusella
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

Review 3.  Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease.

Authors:  Anne Moscona
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

4.  Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.

Authors:  Santanu Bose; Mausumi Basu; Amiya K Banerjee
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.

Authors:  Laura M Palermo; Matteo Porotto; Christine C Yokoyama; Samantha G Palmer; Bruce A Mungall; Olga Greengard; Stefan Niewiesk; Anne Moscona
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

6.  The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence.

Authors:  Zhuhui Huang; Aruna Panda; Subbiah Elankumaran; Dhanasekaran Govindarajan; Daniel D Rockemann; Siba K Samal
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 7.  Arenavirus Quasispecies and Their Biological Implications.

Authors:  Ana Grande-Pérez; Veronica Martin; Hector Moreno; Juan C de la Torre
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

Review 8.  The cell biology of acute childhood respiratory disease: therapeutic implications.

Authors:  Gerald M Loughlin; Anne Moscona
Journal:  Pediatr Clin North Am       Date:  2006-10       Impact factor: 3.278

9.  Modeling Infection and Tropism of Human Parainfluenza Virus Type 3 in Ferrets.

Authors:  Laurine C Rijsbergen; Katharina S Schmitz; Lineke Begeman; Jennifer Drew-Bear; Lennert Gommers; Mart M Lamers; Alexander L Greninger; Bart L Haagmans; Matteo Porotto; Rik L de Swart; Anne Moscona; Rory D de Vries
Journal:  mBio       Date:  2022-02-15       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.